Last updated 30 days ago

Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Follicular Lymphoma

500 patients around the world
Available in Argentina, Brazil
AbbVie
14Research sites
500Patients around the world
This study is for people with
Non-Hodgkin Lymphoma
Follicular lymphoma
Lymphoma
Non-Hodgkin lymphoma
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Sites
CEMIC - Hospital Universitario Sede Saavedra - CABA, Buenos Aires
CEMIC - Hospital Universitario Sede Saavedra - CABA, Buenos Aires
Av. Galvan 4102, CABA, Buenos Aires
Centro de Internación e Investigación Clínica FUNDALEU
J. E. Uriburu 1450, CABA, Buenos Aires
Hospital Privado de Córdoba
Naciones Unidas 346, Córdoba
Clínica de Nefrología Urología y Enfermedades Cardiovasculares - Santa Fe
Av. Freyre 3074, Santa Fe
Beneficência Portuguesa de São Paulo
Recruiting
R. Maestro Cardim, 637 - Bela Vista, São Paulo - SP, 01323-001
Instituto D'Or de Pesquisa e Ensino - Sao Paulo
Recruiting
Av. República do Líbano, 611 - Ibirapuera, São Paulo - SP, 04501-000
Instituto de Assistencia Medica ao Servidor Publico Estadual - IAMSPE
Recruiting
Rua Pedro de Toledo, 1800 - Vila Clementino, São Paulo - SP, 04039-000
Hospital das Clínicas da Faculdade de Medicina da São Paulo - USP
Recruiting
Rua Dr. Ovídio Pires de Campos 785 - Estado de São Paulo 05403-000
Centro de Pesquisas Clinicas da Fundacao Doutor Amaral Carvalho
Recruiting
Jau, 17210080
Hospital De Clínicas Da Universidade Federal Do Paraná
Recruiting
R. Gen. Carneiro, 181 - Alto da Glória, Curitiba - PR, 80060-900
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy